In a climate where there are so many unknown factors challenging valuation methodologies, we explore a number of mechanisms that European dealmakers may consider during the Coronavirus (COVID-19) pandemic in order to bridge...more
12/4/2020
/ Acquisitions ,
Buyers ,
Coronavirus/COVID-19 ,
Deferred Consideration ,
Earn-Outs ,
EBITDA ,
EU ,
Fairness Standard ,
Fixed Price Contracts ,
Global Dealmaking ,
Indemnity Insurance ,
Mergers ,
Sellers ,
Warranty Insurance